Source link : https://newshealth.biz/health-news/copycat-weight-loss-pill-removed-from-the-market-amid-fda-crackdown/
(MedPage Today) — The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the market… Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/119806 Author : Publish date : 2026-02-09 20:19:00 Copyright for syndicated content belongs to the linked […]
The post Copycat Weight-Loss Pill Removed From the Market Amid FDA Crackdown first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-09 20:19:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8